Writer: Vita Ayala
Art: Marcelo Ferreira, Roberto Poggi, Scott Hana, Dono Sanchez-Asmara, and VC’s Clayton Cowles
Price: $3.99
Release Date: December 11th, 2019
Has Morbius’ theft from the Melter helped or hindered him in his quest for a cure for his vampirism? Let’s jump in and find out!
The first thing that peaked my interest in this issue is the art. It’s simply fabulous!! All of it – pencils, inks, and colors.
It’s also apparent right away that in his haste to cure himself, Michael has made matters seemingly worse.
And as his blood lust intensifies, his appearance worsens. 
The art shows this transformation in a staggering fashion that really puts the “horror” in this horror book.
Our vampire hunter that was the cliffhanger of issue one quickly makes an appearance, in hot pursuit of Morbius. Morbius knows the woman but can’t place her name. She also seems to be the Melter’s girlfriend. After a lengthy battle with the woman and the Melter and a flashback, we find that the woman’s name is Elizabeth and that she is out for revenge for her brother Emil dying.
Morbius breaks into a hospital out of desperation looking for blood and medication to help heal his wounds. As Morbius is about to attack a worker after he set off an alarm, he’s stopped from killing him in what is one of the best cliffhangers in recent memory. Knowing in what book Morbius made his first appearance is a clue to the cliffhanger!
Morbius is not a top tier character by any means. He may even be a C or D level character. But with that being said, this is one of the better books I’ve read this week. We’ve got a very flawed character who in an attempt to cure himself, made his vampirism worse, and now his quest to be cured/healed intensifies. We’ve got a vampire hunter with her mind set on revenge and some top tier art as the icing on the cake.
Final Thoughts:
The spectacular art really set the tone in this series. Unlike a few other books I’ve reviewed this week, this issue was actually fun to read. I’m thoroughly enjoying reading it and hope the reasonably good sales will justify this series continuing.